Update shared on 08 Dec 2025
Analysts have raised their price target on SuRo Capital by $1 to $12, citing building momentum across the company's investment portfolio as support for the higher valuation.
Analyst Commentary
Bullish Takeaways
- Bullish analysts highlight that the incremental price target increase reflects growing confidence in the durability of portfolio momentum, supporting a premium to prior valuation levels.
- Recent portfolio performance following the Q3 report is viewed as evidence that management is executing effectively on its investment strategy, underpinning expectations for continued net asset value growth.
- Improved visibility into monetization opportunities within the portfolio is seen as a catalyst for upside to earnings and capital return, which could justify further multiple expansion if successfully realized.
- Analysts note that maintaining a positive rating alongside a higher target signals conviction that the current share price still discounts the full value of the underlying portfolio.
Bearish Takeaways
- Bearish analysts caution that the modest size of the target increase suggests some lingering uncertainty around the timing and magnitude of portfolio exits and liquidity events.
- There is concern that continued momentum is partly dependent on broader market conditions for growth and late stage private companies, which could pressure valuations if sentiment weakens.
- Some analysts remain focused on execution risk, noting that converting paper gains into realized returns requires disciplined exit timing and could face delays.
- Valuation is seen as increasingly sensitive to any slowdown in portfolio performance, leaving limited room for missteps before the shares could retrace from higher target levels.
What's in the News
- Extended share repurchase program, with SuRo Capital lengthening the duration of its buyback plan to October 31, 2026. This signals a continued focus on capital return to shareholders (Key Developments).
- Completion of a substantial portion of the existing buyback authorization, with 5,990,501 shares repurchased to date, representing 28.34% of shares for $39.17 million under the program announced on August 8, 2017 (Key Developments).
Valuation Changes
- Fair Value estimate remains unchanged at $11.15 per share, indicating no revision to the intrinsic value assessment.
- The discount rate has risen slightly from 8.87% to approximately 8.91%, implying a modestly higher required return for valuing future cash flows.
- The revenue growth assumption is effectively unchanged, holding at around negative 18.29%, signaling continued expectations for revenue contraction.
- The net profit margin forecast remains stable at roughly 39.18%, suggesting no material shift in expected profitability levels.
- The future P/E multiple has increased marginally from about 857.6x to 858.5x, reflecting a negligible change in the valuation multiple applied to forward earnings.
Have other thoughts on SuRo Capital?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
